Form 4 Tracker
Kymera Therapeutics, Inc.
KYMR

52 insider filings · Latest: Jul 27, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 15, 2026Apr 16 10:16 PMBruce BoothDirector
Sale
5,335$90.04$480.4K674,956(I)

View →

Apr 14, 2026Apr 16 10:16 PMBruce BoothDirector
Sale
4,159$89.97$374.2K0(D)

View →

Apr 15, 2026Apr 15 8:51 PMAtlas Venture Opportunity Fund I, LP
Proposed Sale
385$89.87$34.6K

View →

Apr 15, 2026Apr 15 8:51 PMAtlas Venture Fund X, LP
Proposed Sale
2,750$89.87$247.1K

View →

Apr 15, 2026Apr 15 8:41 PMJEREMY CHADWICK
Proposed Sale
1,300$89.87$116.8K

View →

Apr 14, 2026Apr 14 9:19 PMBruce Booth
Proposed Sale
24,000$88.53$2.1M

View →

Apr 14, 2026Apr 14 8:37 PMJEREMY CHADWICK
Proposed Sale
5,251$88.53$464.9K

View →

Apr 10, 2026Apr 10 8:45 PMNoah GoodmanChief Business Officer
Sale
2,000$87.35$174.7K51,542.438(D)

View →

Apr 9, 2026Apr 10 8:45 PMNoah GoodmanChief Business Officer
Sale
8,264$87.50$723.1K53,542.438(D)

View →

Apr 9, 2026Apr 9 8:28 PMNoah Goodman
Proposed Sale
11,611$87.35$1.0M

View →

Apr 1, 2026Apr 1 11:00 PMElena RidloffDirector
Sale
4,600$85.42$392.9K0(D)

View →

Apr 1, 2026Apr 1 11:00 PMJeremy G ChadwickChief Operating Officer
Sale
14,640$85.46$1.3M61,202(D)

View →

Mar 31, 2026Apr 1 11:00 PMJeremy G ChadwickChief Operating Officer
Sale
7,600$85.38$648.9K61,202(D)

View →

Mar 31, 2026Apr 1 11:00 PMElena RidloffDirector
Sale
7,400$85.37$631.7K0(D)

View →

Apr 1, 2026Apr 1 8:42 PMELENA RIDLOFF
Proposed Sale
4,600$83.29$383.1K

View →

Apr 1, 2026Apr 1 8:42 PMJEREMY CHADWICK
Proposed Sale
14,640$83.29$1.2M

View →

Mar 31, 2026Mar 31 8:21 PMJEREMY CHADWICK
Proposed Sale
7,600$79.48$604.0K

View →

Mar 31, 2026Mar 31 8:19 PMELENA RIDLOFF
Proposed Sale
7,400$79.48$588.2K

View →

Mar 25, 2026Mar 25 9:15 PMJeremy G ChadwickChief Operating Officer
Sale
24,727$80.26$2.0M61,202(D)

View →

Mar 23, 2026Mar 25 9:15 PMJeremy G ChadwickChief Operating Officer
Sale
91,250$77.41$7.1M61,202(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 2, 2026Mar 4 11:00 PMBruce N. JacobsChief Financial Officer
Grant/Award
35,300$90.1035,300(D)

View →

Mar 2, 2026Mar 4 11:00 PMNello MainolfiDirector, Chief Executive Officer
Grant/Award
215,000$90.10215,000(D)

View →

Feb 25, 2026Feb 25 10:24 PMNello MainolfiDirector, Chief Executive Officer
Option Exercise
30,000$2.08245,559(D)

View →

Feb 20, 2026Feb 20 10:30 PMPamela EspositoDirector
Option Exercise
2,500$49.102,500(D)

View →

Jan 20, 2026Jan 20 11:30 PMPamela EspositoDirector
Option Exercise
5,500$49.105,000(D)

View →

Dec 31, 2025Dec 31 10:23 PMNello MainolfiDirector, Chief Executive Officer
Option Exercise
30,000$2.08275,559(D)

View →

← Previous

Page 3 of 3